Hepatitis in children: 2 new research focuses on probable causes

Their findings reveal it is likely a combination of 3 elements — co-infection with two different viruses and genetic susceptibility

‘Adenovirus is not new. Yet, we’ve never linked it with severe hepatitis’

Matthew R Vogt on link between acute flaccid myelitis & current acute paediatric hepatitis outbreak

Probable cases of acute hepatitis in children cross 600, cause remains unknown 

As many as 38 children required transplants and nine died

Severe hepatitis in children: Why COVID-link hasn’t been ruled out

18 per cent severe hepatitis patients tested positive for COVID-19

86 European, US children down with severe hepatitis; experts perplexed

Some have cited COVID-19 as a reason; some two years of it, while the rest have blamed the adenovirus

COVID-19 : Why vaccinating children may be crucial

Vaccinating children will protect them against post-infectious conditions such as multisystem inflammatory syndrome; reduce risk of infection in …

Access to viral hepatitis diagnosis and treatment is still limited: WHO

In Africa, less than eight countries provide subsidised testing and treatment for viral hepatitis

Simply Put: Hepatitis C virus

A researcher reflects on progress fighting hepatitis C — and a path forward

The development of treatments over the past 30 years reflects the amazing progress the field has made in tackling hepatitis C in a relatively …

Three win Nobel Prize in medicine for discovery of Hepatitis C virus

Harvey J Alter, Michael Houghton and Charles M Rice won the prize for the discovery of the virus that caused several deaths in the 1960s and …

How liver protein can aid in developing vaccine for hepatitis C

More than 70 million globally are affected by chronic hepatitis C virus, increasing the risk for the more fatal liver cancer or cirrhosis

The 'vaccinegate' of Italy

A study in Italy has found major contaminants in vaccines that are used the world over

This is why Hepatitis B, Hepatitis C are dangerous

Just one in 10 infected know their status and many are unaware that the inflamation of the liver is a common and treatable disease

Only 5 per cent of people infected with hepatitis B virus receive treatment

While 94 million people out of 292 million hepatitis B patients in 2016 were eligible for antiviral treatment, just 4.8 million got it, says a study

Birth dose of hepatitis B vaccine may not be necessary: ICMR

Many newborns are protected from Hepatitis B infection by antibodies they receive from the mother and therefore, hepatitis B vaccination at birth …

Southeast Asia has a huge hepatitis burden—more than HIV and malaria combined

The region needs to enhance awareness and action to eliminate hepatitis, writes WHO regional director for southeast Asia s 

Civil society challenges patents on Hepatitis C drugs

Pharmaceutical corporations obtain unjustified patents making the drugs unaffordable to many, petitioners claim  

UNICEF to procure controversial pentavalent vaccine at lowest-ever prices

This step will significantly increase the distribution of pentavalent vaccine, which has been blamed for adverse health effects

What to do about Liberia's island colony of abandoned lab chimps?

These chimpanzees were intentionally infected with hepatitis and other pathogens to help develop a range of vaccines

Hepatitis C: India has failed to tackle the deadly disease

Chronic HCV infection accounts for 12-32 per cent of liver cancer and 10-20 per cent of cirrhosis cases in India. Most people with chronic …

Children under five account for 30 per cent of deaths due to food borne diseases globally: WHO

Calls food borne diseases a ‘global concern’

Gilead signs agreements with Indian generic companies for hepatitis C drug

Indian companies granted licence to produce generic sofosbuvir and investigational single tablet regimen of ledipasvir/sofosbuvir for treatment …

Policy draft backs new vaccines

Health experts say new vaccines not essential enough to be in the national programme

Muted response

Hepatitis C is a growing problem in India, but government has no programme to manage the disease

Gilead expands hepatitis C licensing pacts with Indian companies

New programme introduces coercion and policing upon medical providers and may result in treatment interruptions for patients